首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cardiovascular pathology

缩写:CARDIOVASC PATHOL

ISSN:1054-8807

e-ISSN:1879-1336

IF/分区:1.9/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引1238
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Dehui Li,Haichu Wen,Bokang Qiao et al. Dehui Li et al.
Background: Epidemiological evidence has established a strong association between iron deficiency (ID) and the exacerbation of heart failure (HF) and increased mortality. However, the molecular mechanisms by which iron de...
Isaac Chung,Mary Sheppard,Joseph Westaby Isaac Chung
Atrial fibrillation (AF) is the most common heart rhythm disorder with an estimated prevalence of 2-4% in adults. AF is a recognised risk factor for sudden cardiac death (SCD) and has been associated with most cardiac diseases. As the atria...
Gregory A Fishbein,Marc K Halushka Gregory A Fishbein
Cardiac allograft rejection has traditionally been assessed by endomyocardial biopsy (EMB). Blood-based assays such as donor-derived cell-free DNA (dd-cfDNA) are increasingly used, yet emerging data highlight discordance between these appro...
Eleonora Nardi,Chiara Siodambro,Letizia Del Bello et al. Eleonora Nardi et al.
Anorexia nervosa is associated with severe cardiovascular complications and an increased risk of sudden death. While cardiac atrophy is well recognized, unusual connective-tissue alterations of the heart are rarely described. A 28-year-old ...
Justin Burk,Alexander N Wein,Michael M Binkley et al. Justin Burk et al.
Introduction: Despite imaging advancements, proper management for cardiac amyloidosis hinges on accurate diagnosis and subtyping of amyloid in endomyocardial biopsies (EMBx). Nonetheless, the approach toward identifying a...
Hiromitsu Kanamori,Tamami Yoshida,Matsumoto Hideki et al. Hiromitsu Kanamori et al.
Fabry disease, characterized by α-galactosidase A (GLA) deficiency, causes left ventricular hypertrophy (LVH) often mimicking hypertrophic cardiomyopathy (HCM). Differentiating Fabry disease from HCM is crucial, given their therapeutic and...
Yifan Wang,Weiteng Wang,Han Mo et al. Yifan Wang et al.
Background: Left ventricular hypertrabeculation/non-compaction (LVHT/LVNC) is characterized by a thinned myocardial wall, prominent trabeculations, and deep intertrabecular recesses. It presents with unique cardiac morpho...